Darwin Global Management, Ltd.
Q4 2025 13F Holdings
- Locationst. helier, Y9
- Num holdings
6
- Value ($000)
$4,939,420
- Date Filed02/17/2026
- Form type13F-HR
- CIK0001839209
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
INSMED INC | COM PAR $.01 | 457669307 | $3.64B | 74 % | 20,933,277 | ||
BELITE BIO INC | SPONSORED ADS | 07782B104 | $486.92M | 10 % | 3,027,704 | ||
ABIVAX SA | SPONSORED ADS | 00370M103 | $439.71M | 9 % | 3,178,501 | ||
CIDARA THERAPEUTICS INC | COM NEW | 171757206 | $220.18M | 5 % | 997,196 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | $125.17M | 3 % | 7,298,421 | ||
CAPRICOR THERAPEUTICS INC | COM NEW | 14070B309 | $23.17M | 1 % | 800,000 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100